Literature DB >> 16417697

The efficacy of combining several risk factors as a screening test.

Nicholas J Wald1, Joan K Morris, Simon Rish.   

Abstract

OBJECTIVE: To determine the quantitative effect on overall screening performance (detection rate for a given false-positive rate) of using several moderately strong, independent risk factors in combination as screening markers.
SETTING: Theoretical statistical analysis.
METHODS: For the purposes of this analysis, it was assumed that all risk factors were independent, had Gaussian distributions with the same standard deviation in affected and unaffected individuals and had the same screening performance. We determined the overall screening performance associated with using an increasing number of risk factors together, with each risk factor having a detection rate of 10%, 15% or 20% for a 5% false-positive rate. The overall screening performance was estimated as the detection rate for a 5% false-positive rate.
RESULTS: Combining the risk factors increased the screening performance, but the gain in detection at a constant false-positive rate was relatively modest and diminished with the addition of each risk factor. Combining three risk factors, each with a 15% detection rate for a 5% false-positive rate, yields a 28% detection rate. Combining five risk factors increases the detection rate to 39%. If the individual risk factors have a detection rate of 10% for a 5% false-positive rate, it would require combining about 15 such risk factors to achieve a comparable overall detection rate (41%).
CONCLUSION: It is intuitively thought that combining moderately strong risk factors can substantially improve screening performance. For example, most cardiovascular risk factors that may be used in screening for ischaemic heart disease events, such as serum cholesterol and blood pressure, have a relatively modest screening performance (about 15% detection rate for a 5% false-positive rate). It would require the combination of about 15 or 20 such risk factors to achieve detection rates of about 80% for a 5% false-positive rate. This is impractical, given the risk factors so far discovered, because there are too few risk factors and their associations with disease are too weak.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16417697     DOI: 10.1258/096914105775220642

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  16 in total

1.  Discriminative accuracy of genomic profiling comparing multiplicative and additive risk models.

Authors:  Ramal Moonesinghe; Muin J Khoury; Tiebin Liu; A Cecile J W Janssens
Journal:  Eur J Hum Genet       Date:  2010-11-17       Impact factor: 4.246

2.  Drug therapies for the primary prevention of cardiovascular events: trials and errors: 2009 Ancel Keys Memorial Lecture.

Authors:  Bruce M Psaty
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

3.  Problems with performance related pay in primary care.

Authors:  David S Wald
Journal:  BMJ       Date:  2007-09-15

4.  Evaluation of the discriminative accuracy of genomic profiling in the prediction of common complex diseases.

Authors:  Ramal Moonesinghe; Tiebin Liu; Muin J Khoury
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

5.  The SHAPE guideline: ahead of its time or just in time?

Authors:  Erling Falk; Prediman K Shah
Journal:  Curr Atheroscler Rep       Date:  2011-10       Impact factor: 5.113

Review 6.  Role of C-reactive protein when prescribing a statin.

Authors:  Scott Kinlay
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

7.  Screening for future cardiovascular disease using age alone compared with multiple risk factors and age.

Authors:  Nicholas J Wald; Mark Simmonds; Joan K Morris
Journal:  PLoS One       Date:  2011-05-04       Impact factor: 3.240

8.  The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population.

Authors:  Erling Falk; Henrik Sillesen; Pieter Muntendam; Valentin Fuster
Journal:  Curr Atheroscler Rep       Date:  2011-10       Impact factor: 5.113

Review 9.  Utility of genetic determinants of lipids and cardiovascular events in assessing risk.

Authors:  Michael V Holmes; Seamus Harrison; Philippa J Talmud; Aroon D Hingorani; Steve E Humphries
Journal:  Nat Rev Cardiol       Date:  2011-02-15       Impact factor: 32.419

Review 10.  Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.

Authors:  Tina Shah; Juan P Casas; Jackie A Cooper; Ioanna Tzoulaki; Reecha Sofat; Valerie McCormack; Liam Smeeth; John E Deanfield; Gordon D Lowe; Ann Rumley; F Gerald R Fowkes; Steve E Humphries; Aroon D Hingorani
Journal:  Int J Epidemiol       Date:  2008-10-17       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.